Skip to main content
Clinical Trials/ISRCTN70713571
ISRCTN70713571Completed未知

Improvement of primary health care of patients with poorly regulated diabetes mellitus type 2 using shared decision-making

German Federal Ministry of Education and Research (BMBF) (Germany)0 sites833 target enrollmentStarted: June 17, 2011Last updated:

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
833

Study Overview

Brief Summary

2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/31238871 results (added 27/06/2019) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33992088/ (added 17/05/2021) 2023 Results article in https://doi.org/10.1186/s12875-023-02067-9 Secondary analysis (added 15/05/2023)

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • Current inclusion criteria as of 30/06/2015:
  • 1. Diabetes mellitus type 2
  • 2. HbA1c level of 8.0 or above at the time of recruitment
  • 3. Ability to informed consent
  • 4. Fluency in the German language
  • 1. General practitioner or internist, working as GP or practitioner with KV admission (Association of Statutory Health Insurance Physicians)
  • Previous inclusion criteria from 10/01/2012 to 30/06/2015:
  • 1. Diabetes mellitus type 2
  • 2. HbA1c level of 8.1 or above at the time of recruitment
  • 3. Ability to informed consent
  • 4. Fluency in the German language
  • 1. General practitioner or internist, working as GP or practitioner with KV admission (Association of Statutory Health Insurance Physicians)
  • Original inclusion criteria until 10/01/2012:
  • 1. Diabetes mellitus type 2
  • 2. HbA1c level of 8.5 or above at the time of recruitment
  • 3. Ability to informed consent
  • 4. Fluency in the German language
  • 1. General practitioner or internist, working as GP or practitioner with KV admission (Association of Statutory Health Insurance Physicians)
  • 2. Participation on the Disease Management Program diabetes mellitus type 2

Exclusion Criteria

  • 1. Severe comorbidity
  • 2. Life expectancy of less than 18 months

Investigators

Sponsor
German Federal Ministry of Education and Research (BMBF) (Germany)

Similar Trials